Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dyadic International (DYAI)

Dyadic International (DYAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dyadic International 1044 North U.S. Highway One Suite 201 JUPITER FL 33477 USA

www.dyadic.com Employees: 7 P: 561-743-8333 F: 561-743-8343

Description:

Dyadic International, Inc. is a leading genomics company with the groundbreaking technology that brings nature to the marketplace. Dyadic is poised to become a global leader in proteomics through the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms including humans found in the earth's biodiversity. Using its integrated technology platform, Dyadic develops biological products such as proteins, enzymes, polypeptides and small molecules for applications in large segments of the agricultural, industrial, chemical and biopharmaceutical industries. By utilizing a proprietary host organism, Dyadic's `one-stop shop` technology rapidly discovers and expresses eukaryotic genes the genes of complex living organisms and then manufactures those unique biological products for commercial application. Dyadic's systems overcome the inadequacy of existing gene discovery and product development techniques.

Key Statistics

Overview:

Market Capitalization, $K 34,619
Enterprise Value, $K 28,099
Shares Outstanding, K 29,589
Annual Sales, $ 2,900 K
Annual Net Income, $ -6,800 K
Last Quarter Sales, $ 1,960 K
Last Quarter Net Income, $ -200 K
EBIT, $ -6,540 K
EBITDA, $ -6,590 K
60-Month Beta 0.72
% of Insider Shareholders 28.80%
% of Institutional Shareholders 27.95%
Float, K 21,067
% Float 71.20%
Short Volume Ratio 0.18

Growth:

1-Year Return -28.65%
3-Year Return -68.42%
5-Year Return -81.07%
5-Year Revenue Growth 123.08%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -0.23
EPS Growth vs. Prev Qtr 85.71%
EPS Growth vs. Prev Year 83.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

DYAI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -149.16%
Return-on-Assets % -59.81%
Profit Margin % -234.48%
Debt/Equity 0.00
Price/Sales 11.53
Price/Cash Flow N/A
Price/Book 9.76
Book Value/Share 0.12
Interest Coverage -0.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar